BridgeBio Oncology Therapeutics, Inc.
BridgeBio Oncology Therapeutics, Inc. financial statements
BridgeBio Oncology Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 134.04M | 10-K |
| Cash and equivalents | USD 373.69M | 10-Q |
| Total debt | USD 2.77M | EODHD |
BridgeBio Oncology Therapeutics, Inc. financials on 6ix · BridgeBio Oncology Therapeutics, Inc. on 6ix